US 9944596
Heterocyclic compound
granted A61KA61K31/40A61K31/401
Quick answer
US patent 9944596 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/40, A61K31/401, A61P, A61P27/02